Compile Data Set for Download or QSAR
maximum 50k data
Found 56 of ki for UniProtKB: P0DPI1
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506811(US11046652, Example 1-5)
Affinity DataKi:  3.20nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506825(US11046652, Example 2-4)
Affinity DataKi:  4.5nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506834(US11046652, Example 3-7)
Affinity DataKi:  5.10nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506835(US11046652, Example 3-8)
Affinity DataKi:  5.40nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506829(US11046652, Example 3-2)
Affinity DataKi:  5.40nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506807(US11046652, Example 1-1 | US11046652, Example 2-1)
Affinity DataKi:  5.70nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506807(US11046652, Example 1-1 | US11046652, Example 2-1)
Affinity DataKi:  6.10nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506813(US11046652, Example 1-7)
Affinity DataKi:  6.20nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506832(US11046652, Example 3-5)
Affinity DataKi:  6.40nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506808(US11046652, Example 1-2 | US11046652, Example 1-3)
Affinity DataKi:  6.40nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506841(US11046652, Example 5-1)
Affinity DataKi:  7.10nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506815(US11046652, Example 1-9)
Affinity DataKi:  8.20nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506833(US11046652, Example 3-6)
Affinity DataKi:  9.5nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506828(US11046652, Example 3-1)
Affinity DataKi:  10.2nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506810(US11046652, Example 1-4)
Affinity DataKi:  13.8nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506814(US11046652, Example 1-8)
Affinity DataKi:  14.7nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506821(US11046652, Example 1-15)
Affinity DataKi:  17.8nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506812(US11046652, Example 1-6)
Affinity DataKi:  18nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506819(US11046652, Example 1-13)
Affinity DataKi:  19nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506820(US11046652, Example 1-14)
Affinity DataKi:  20.4nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506808(US11046652, Example 1-2 | US11046652, Example 1-3)
Affinity DataKi:  21.3nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506823(US11046652, Example 2-2)
Affinity DataKi:  24.5nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506824(US11046652, Example 2-3)
Affinity DataKi:  26nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506818(US11046652, Example 1-12)
Affinity DataKi:  28nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506837(US11046652, Example 3-10 | US11046652, Example 3-1...)
Affinity DataKi:  30.6nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506836(US11046652, Example 3-9)
Affinity DataKi:  31.7nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506840(US11046652, Example 4-2)
Affinity DataKi:  33.3nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506816(US11046652, Example 1-10)
Affinity DataKi:  39.8nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506817(US11046652, Example 1-11)
Affinity DataKi:  44nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506837(US11046652, Example 3-10 | US11046652, Example 3-1...)
Affinity DataKi:  53nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506827(US11046652, Example 2-6)
Affinity DataKi:  118nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506839(US11046652, Example 4-1)
Affinity DataKi:  182nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506831(US11046652, Example 3-4)
Affinity DataKi:  207nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506826(US11046652, Example 2-5)
Affinity DataKi:  214nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506842(US11046652, Example 5-2)
Affinity DataKi:  246nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506843(US11046652, Example 5-3)
Affinity DataKi:  299nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50260295(2-((S)-2-(2-((S)-2-((S)-2-((S)-6-amino-2-((2S,3R)-...)
Affinity DataKi:  300nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50242333((S)-2-{(S)-2-[(S)-6-Amino-2-((2S,3R)-2-{(S)-2-[(S)...)
Affinity DataKi:  300nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50260294((S)-2-((S)-6-amino-2-((2S,3R)-2-((S)-2-((S)-5-guan...)
Affinity DataKi:  400nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506830(US11046652, Example 3-3)
Affinity DataKi:  623nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506844(US11046652, Example 5-4)
Affinity DataKi:  629nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50242339((S)-2-{(S)-2-[(S)-6-Amino-2-((2S,3R)-2-{(S)-2-[(S)...)
Affinity DataKi:  700nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50242337((S)-2-{(S)-2-[(S)-6-Amino-2-((S)-2-{(S)-2-[(S)-5-g...)
Affinity DataKi:  700nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50242336((S)-2-{(S)-2-[(S)-6-Amino-2-((2S,3R)-2-{(S)-2-[(S)...)
Affinity DataKi:  2.00E+3nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50260296(CHEMBL501525 | CRATKML)
Affinity DataKi:  2.00E+3nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50240902((2E)-2-{4-[6-((E)-{[(E)-amino(imino)methyl]hydrazo...)
Affinity DataKi:  3.00E+3nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50242338((S)-2-{(S)-2-[(S)-2-((2S,3R)-2-{(S)-2-[(S)-5-Guani...)
Affinity DataKi:  3.00E+3nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50260293((S)-6-amino-2-((2S,3R)-2-((S)-2-((S)-5-guanidino-2...)
Affinity DataKi:  4.00E+3nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A(Clostridium botulinum (strain Hall / ATCC 3502 / N...)
National Cancer Institute-Frederick

Curated by ChEMBL
LigandPNGBDBM50240901(2-((1E,3E,5E)-6-{5-[(E)-amino(imino)methyl]-1-benz...)
Affinity DataKi:  6.00E+3nMAssay Description:Inhibition of BoNT/A light chain metalloprotease activityMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBotulinum neurotoxin type A [1-429](Clostridium botulinum (strain Hall / ATCC 3502 / N...)
Hawaii Biotech

US Patent
LigandPNGBDBM506845(US11046652, Example 5-5)
Affinity DataKi:  7.45E+3nMAssay Description:In a 96 well, clear bottom black plate, the following was added to each well: 5 nM BoNT/A LC1-429, 28 μM substrate in 30 mM HEPES pH 7.3, 0.05 m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: